BOSENTAN AN bosentan (as monohydrate) 62.5 mg film-coated tablet bottle

Land: Australien

Sprache: Englisch

Quelle: Department of Health (Therapeutic Goods Administration)

Wirkstoff:

bosentan monohydrate, Quantity: 64.541 mg

Verfügbar ab:

Amneal Pharma Australia Pty Ltd

INN (Internationale Bezeichnung):

bosentan monohydrate

Darreichungsform:

Tablet, film coated

Zusammensetzung:

Excipient Ingredients: povidone; maize starch; magnesium stearate; sodium starch glycollate type A; glycerol dibehenate; pregelatinised maize starch; titanium dioxide; hypromellose; purified talc; triacetin; iron oxide yellow; iron oxide red; ethylcellulose

Verabreichungsweg:

Oral

Einheiten im Paket:

60

Verschreibungstyp:

(S4) Prescription Only Medicine

Anwendungsgebiete:

for the treatment of,? idiopathic pulmonary arterial hypertension,? familial pulmonary arterial hypertension,? pulmonary arterial hypertension associated with scleroderma or,? pulmonary arterial hypertension associated with congenital systemic to pulmonary shunts including Eisenmenger?s physiology,in patients with WHO functional Class II, III or IV symptoms

Produktbesonderheiten:

Visual Identification: Orange, round, biconvex, film coated tablets, debossed with AN on one side and 873 on the other side.; Container Type: Bottle; Container Material: HDPE; Container Life Time: 18 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Child resistant closure

Berechtigungsstatus:

Licence status A

Berechtigungsdatum:

2017-08-22